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Amousepulmonaryhypersensitivityexperimentalmodelthatmimicshumanasthmawasdevelopedandelectroacupuncture(EA)
treatment was shown to reduce allergic inﬂammatory processes. In addition, we also assessed whether the beneﬁcial eﬀects of EA
on allergic asthma could be correlated with CD4+CD25+Foxp3+ regulatory T cells (Treg). Cellular proﬁles and histopathologic
analysis demonstrated that peribronchial and perivascular inﬂammatory cell inﬁltrates were signiﬁcantly decreased in the EA-
treated groups when compared to the OVA and anti-CD25 Ab injected (Treg depletion) groups. Furthermore, total BAL cells
were reduced in the EA groups when compared to other groups. Interestingly, the population of CD4+CD25+Foxp3+Tregs in
pneumonocytes increased in EA-treated group when compared to OVA and Treg depletion groups. These results imply that EA
stimulation at ST 36 may aﬀect CD4+CD25+Foxp3+ Treg in an OVA-induced experimental model, and may enhance Treg function
by suppressing other T cells and limiting the immune response.
1.Introduction
Acupuncture is the clinical insertion and manipulation of
thin needles into speciﬁc body sites, the so-called acupoints
on the meridian, and is based on the ancient theory of
oriental medicine. This process is believed to elicit profound
psychophysical responses by harmonizing or balancing the
energy and blood ﬂow through the body. EA is a modiﬁed
technique of acupuncture that requires electrical stimu-
lation. Several studies have reported that EA stimulation
is eﬀective for the treatment of allergic disorders caused
by an imbalance of the Th1/Th2 cell response, such as
asthma [1–4]. Allergic asthma is an inﬂammatory process
driven by inappropriate Th2 immune responses against
otherwiseinnocuousenvironmentalallergens[5–7],andalso
involves complex neuroimmune deregulation that promotes
bronchial inﬁltration of inﬂammatory leukocytes, which
results in exacerbated mucus production, epithelial damage,
airway hyperresponsiveness (AHR) and tissue remodel-
ing. This response is characterized by airway inﬁltration
of diverse eﬀe c t o r sc e l l ss u c ha sm o n o c y t e s ,m a s tc e l l s ,
neutrophils, T lymphocytes, and eosinophils [8, 9]. The
underlying process that drives and maintains the asthmatic
inﬂammatory process appears to be an imbalance of the
equilibrium between the Th1 and Th2 immune response
types, with a predominance of Th2 [10]. Our previous study
showedthatEAreducesIgEinBALB/cmiceimmunizedwith
2,4-dinitrophenylated keyhole limpet protein (DNP-KLH)
throughthesuppressionofTh2cytokines[11,12].Andthese
eﬀects were mediated by α-adrenoreceptor [12]. Recently,
regulatory T (Treg) cells are shown to be key downregulatory
cells that are capable of preventing allergic sensitization
and progression of allergic disease, including asthma. Treg
cells are important components of the homeostasis of the
immune system, since impaired CD4+CD25+ T-cells activity
can cause autoimmune diseases and allergy [7, 13]. Espe-
cially, Foxp3 is a transcription factor that is predominantly
expressed in CD4+CD25+ Treg cells and is a master regulator
of the development and function of Treg cells [14–16]. Tregs
have been found to lose Foxp3 expression when converted2 Evidence-Based Complementary and Alternative Medicine
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Figure 1: Schematic diagram of the experimental protocol. On days 0 to 14, mice were divided into control (PBS-treated) and OVA-induced
asthmatic groups. On day 18, OVA-induced asthmatic group was separated into 4 groups (OVA-immunized group; EA-treated after OVA
induction group; anti-CD25 antibody injection after OVA induction group; EA-treated after OVA induction; anti-CD25 antibody injection
group). Mice were immunized i.p. with 0.25mg of anti-CD25 antibody 3 days before intranasal challenge. On day 21, all of OVA-induced
asthmatic groups received 1% OVA in 50μL PBS or PBS intranasally and after 10 minutes, EA treatments at ST36 were applied for another
10 minutes. Acupuncture stimulations were repeated for ten days consecutively after intranasal challenge.
into proinﬂammatory helper cells or CD4+ follicular helper
cells [17–19]. In addition, Treg cells actively control or
suppressthefunctionofothercells,generallyinaninhibitory
fashion, and play an essential role in the maintenance of
peripheral self-tolerance by preventing the activation and
proliferation of autoreactive T cells. These cells appear
to control the development of autoimmune diseases and
transplant rejection and may also play a critical role in
controlling allergic diseases including atopic asthma [20–
22]. Given the reasonable capacity of Treg cells to suppress
the diseases-promoting immune responses, enhancing Tregs
function may be an attractive therapeutic strategy for the
treatment of allergic diseases and asthma. These previous
observations, together with other reports concerning the
anti-inﬂammatory action of acupuncture, led us to examine
the eﬀect of acupuncture on an experimental asthma model
to better understand some of the immunologic eﬀects of
acupuncture. In this study, we also evaluated the antiallergic
asthma mechanisms of EA on OVA-induced allergic asthma
mice.
2.MaterialsandMethods
2.1. Animals. Balb/c female littermates (6 to 8 weeks of
age, weighing 20–25g) were purchased from Orient Bio
(Seoungnam, South Korea). Foxp3+EGFP Balb/c (C. Cg-
Foxp3tm2Tch/ J )m i c ew e r ep u r c h a s e df r o mT h eJ a c k s o n
Laboratory (Bar Harbor, ME, USA). All mice were kept
under pathogen-free conditions using air conditioners and
a 12-h light/dark cycle. In addition, all mice had free access
to food and water during the experiments. The study was
conducted according to the Rules for Animal Care and the
Guiding Principles for Animal Experiments Using animal
by the University of Kyung Hee Animal Care and Use
Committee and in accordance with the recommendations
of the Weatherall report, “The use of non-human primates
in research.” The protocols for the experimental procedures
were approved by the Animal Welfare and Animal Care
Committee of the University of Kyung Hee Animal Care and
Use Committee (KHUASP(SE)-09-017).
2.2. Induction of Allergic Asthma. Female mice 6–8 weeks of
age were sensitized by intraperitoneal (i.p) injection on days
0 and 14 with 100μg of ovalbumin (OVA) (Sigma-Aldrich,
St. Louis, MO, USA) precipitated with 20mg of aluminum
hydroxide in 100μL of PBS. The mice were then challenged
by administering 1% OVA in 50μL PBS or PBS directly into
the nostrils using a micropipetor on days 21–30. Negative
control mice were sensitized and challenged with PBS alone.
On day 31, the mice were sacriﬁced, and various tissues were
collected for analyses.
2.3. Experimental Protocol and Design. On days 0 to 14, mice
were divided into control (PBS-treated) and OVA-induced
asthmatic groups. On day 18, OVA-induced asthmatic group
was separated into 4 groups (OVA-treated group; OVA +
EA group; OVA and anti-CD25 antibody injection group;
OVA and anti-CD25 antibody injection + EA group). Mice
were treated i.p. with 0.25mg of anti-CD25 antibodies 3
days before intranasal challenge. On day 21, all OVA-induced
asthmatic groups received 1% OVA in 50μL PBS or PBS
intranasally, and after 10 minutes, EA stimulation at ST36
was performed. EA stimulation was applied for 10 minutes
and repeated for ten consecutive days for 10min. after
intranasal challenge (Figure 1).
2.4. Depletion of CD4+CD25+ TC e l l sI nV i v o .Anti-mouse
CD25 rat IgG1 (anti-CD25; clone PC61) were generated
in-house from hybridomas obtained from American Type
Culture Collection (Manassas, VA, USA). A dose of 0.25mg
of the anti-CD25 antibody was injected 3 days before
ovalbumin i.p. administration. The eﬃcacy of CD4+CD25+
Tregcelldepletionwasconﬁrmedbyﬂowcytometryanalysis,
using PE-anti-mouse CD25 and ﬂuorescein isothiocyanate-
anti-mouse CD4 (Figure 2).
2.5. EA Stimulation at ST 36. Acupoint ST36 has been
used to treat asthma. Acupoint ST36 is located 5mm below
and lateral to the anterior tubercle of the tibia. Electrical
stimulation was applied to ST36 using two outlets via two
needles.Theneedles(length3.0cm;diameter0.20mm)were
inserted perpendicular to the skin, 5mm from each other,
and about 5mm to one side of the anterior tibial muscle.
An electrical pulse of 3–5V for a, duration 0.25ms and
frequency of 1Hz was delivered from an EA stimulator,Evidence-Based Complementary and Alternative Medicine 3
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Figure 2: Conﬁrmation of CD4+CD25+ Treg cells depletion. PBS treatment alone; anti-CD25 antibody injection into WT Balb/c Foxp3+EGFP
(anti-CD25). Balb/c mice received injections of 0.25mg of anti-CD25 antibody after OVA sensitization. The eﬃcacy of CD4+CD25+ Treg
cells depletion was conﬁrmed by ﬂow cytometry analysis using, PE-anti-mouse CD25 and Foxp3+EGFP. Data are shown as mean ± S.E.M.
(∗∗∗P<0.001 versus control n = 4).
PG-306 (YoungMok, Japan). The intensity of stimulation
was determined to be the minimum voltage that caused
moderate muscle contraction. EA stimulation was applied
for 10 minutes. Control mice were restrained in acrylic
holders without EA stimulation for 10min to normalize
stresses across the groups. Acupuncture stimulations were
repeated for ten consecutive days for 10min after intranasal
challenge.
2.6. Fluorescence-Activated Cell Sorting and Flow Cytometric
Analysis. Lungs were removed, washed with PBS to remove
blood, minced and erythrocyte were lysed in 1% RBC lysis
buﬀer (BD, Pharmingen) for 5 minutes. After RBC lysis, the
lung tissues were forced through a 25μm cell strainer. Cells
were washed three times and resuspended in FCM buﬀer
(PBS with 2% FBS and 0.1% NaN3). Single-cell suspensions
and pneumonocytes obtained from Foxp3EGFP Balc/C mice
were labeled with anti-CD4-APC and anti-CD25-PE mAb
using standard staining methods, and the percentage of
cells stained with a particular reagent was analyzed by
FACSCalibur using the CellQuest software (BD Bioscience).
2.7. Bronchoalveolar Lavage (BAL). BAL was collected by
infusion and extraction of 1mL of ice-cold PBS. This was
repeated three times, and the lavages pooled (mean volume,
± 2.0mL). Recovered BAL (70–80%) was centrifuged at
13000rpm for 10min. The cell pallets were resuspended in
1mL PBS, and the cells were adhered to glass slides using
cytocentrifugation. Total viable cell counts were determined
in a hemocytometer using trypan blue exclusion. Diﬀer-
ential counts of eosinophils, neutrophils, lymphocytes, and
macrophages were determined on cytospin smears of BALF
samples (5 × 105/200μL cells) from individual mice stained
with Diﬀ-Quick staining (Life Technologies, Auckland, New
Zealand) after counting 500 cells. The BAL ﬂuid was then
centrifugedandthesupernatantswerekeptat −70◦C.Results
are expressed as total cell number ×104.
2.8. Assessment of Th2 Cytokines in BAL Fluid Using Enzyme-
Linked Immunosorbent Assay (ELISA). The concentration of
Th2 cytokines IL-4, IL-5, and IL-13 was measured using a
quantitative sandwich enzyme-linked immunoassay kit (BD,
San Diego, CA, USA, for IL-4,5 and R&D, Minneapolis, MN
USA,forIL-13).A96-wellmicrotiterplate(Costar,NY,USA)
was incubated overnight at 4◦C with anti-mouse IL-4, IL-5,
and IL-13 monoclonal antibodies in coating buﬀer, washed
with PBS containing 0.05% tween 20 (Sigma, MO, USA) and
blocked with 5% FBS in PBS and 1% BSA in PBS for 1 hour
at4◦Candroomtemperature.100μLofBALﬂuidswerethen
incubated for two hours at room temperature. Secondary
peroxidase labeled biotinylated anti-mouse IL-4, IL-5, and
IL-13 monoclonal antibodies were then incubated for 1
hour. Finally, the plates were treated with the TMB substrate
solution (KPL, San Diego, CA, USA) for 30min, and the
reaction was stopped with the addition of the TMB stop
solution (50μL per well). Optical density was measured at
450nm in a microplate reader (SOFT max PRO, version 3.1
software, CA, USA). The detection limits for IL-4, IL-5, and
IL-13 were 500, 1000pg/mL, and 100ng/mL, respectively.4 Evidence-Based Complementary and Alternative Medicine
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Figure 3: Flow cytometry analysis of splenic CD4+CD25+Foxp3+ Treg cells. WT Foxp3EGFP mice were sacriﬁced after 10 days of EA
stimulation. Isolated splenocytes were stained with anti-CD4 allophycocyanin (APC) and anti-CD25 PE and submitted to ﬂow cytometry
analysis. At ﬁrst, CD4+ cells were gated (not shown), and then CD25+ and Foxp3 EGFP−positive cells were analyzed. The average ﬂow cytometry
analysis data of CD4+CD25+Foxp3+ Treg cells (WT 4.28%; EA-treated at ST36 8.25%; EA-treated at tail 6.79%) were represented. Data are
shown as mean ±S.E.M. (∗P<0.05; ∗∗P<0.01 versus WT; n = 5).
2.9. Determination of IgE Titers Using ELISA. For serum
analysis, 96-well immunomicroplates (Costar, NY, USA)
were coated with anti-mouse IgE monoclonal antibodies.
The serum was diluted 1:250 with 5% FBS in PBS (assay
diluent), and IgE levels (BD Pharmingen) were measured
using standardized sandwich ELISAs according to the manu-
facturer’s protocol. Optical density was measured at 450nm
inamicroplate reader(SOFTmax PRO,version3.1software,
CA, USA). The detection limit of the IgE ELISA was
100ng/mL.
2.10. Histological Examination. Trachea and lung tissues
were removed from mice and ﬁxed in 4% paraformaldehyde
and then embedded in paraﬃn, after dehydration, cut into
4μm sections, and stained with hematoxylin and eosin
(H&E) and periodic acid schiﬀ reagent (PAS).
2.11. Statistical Analysis. Statistical analysis of the data was
conducted using the Prism 5 software (GraphPad Software
Inc.,CA,USA).Allvaluesarepresentedasthemeans±S.E.M.
Diﬀerences between the means of the control and treatment
samples were determined by one-way ANOVA or Student’s
t-test. Results with a P<0.05 were considered statistically
signiﬁcant.
3. Results
3.1. EA Promotes an Increase in CD4+CD25+Foxp3+ Treg
Cells. To determine whether EA aﬀects CD4+CD25+Foxp3+
Treg cells, EA stimulation at ST36 and a nonacupoint
(tail), were applied for every 10 days to WT Balb/c
Foxp3EGFP mice (WT). Mice were sacriﬁced and splenocytes
were then immunoﬂuorescently stained with anti-CD4
allophycocyanin (APC) and anti-CD25 PE. CD25+ and
Foxp3EGFP−positive cells were analyzed using CD4+-gated
cells. The EA at ST36 group increased the percentage of
CD4+CD25+Foxp3+ Treg cells from 4.28% to 8.25% (P<
0.01) when compared with the WT group (Figure 3). The
Treg cells in nonacupoint mice also increased from 4.28% to
6.79% (P<0.01) relative to WT mice; however, the eﬀect of
EA at ST 36 was more signiﬁcant. Therefore, EA induced a
prominent increase of CD4+CD25+Foxp3+ Treg cells in the
splenocyte cell population of WT mice.
3.2. The Eﬀects of EA on CD4+CD25+Foxp3+ Treg Cells
in OVA-Induced Asthmatic Mice and Treg Cell-Depleted
Mice. To evaluate the eﬀects of EA on CD4+CD25+ Treg
cells in vivo, the expression of CD4+CD25+Foxp3+ in
Treg cells was analyzed in pneumonocytes of asth-
matic Foxp3EGFP mice. Flow cytometry analysis was con-
ducted using pneumonocytes from OVA-induced asthmatic
Foxp3EGFP mice (OVA) that had been sacriﬁced 32days after
EA treatment. The pneumonocytes were then immunoﬂu-
orescently stained with anti-CD4 allophycocyanin (APC)
and anti-CD25 PE, and the Foxp3EGFP population was
analyzed. Among the asthmatic groups, the EA-treated
group had a higher percentage of CD4+CD25+Foxp3+ Treg
cells, which increased from 6.96% to 8.19% (P<0.01)
relative to the OVA group (Figure 4). We also examined
the eﬀects of injecting anti-CD25 Ab (PC61) on OVA-
induced asthmatic mice to better understand the role of
Treg cells in allergic asthma and to determine a possible
relationshipbetweenTregcellsandEA.AsshowninFigure 4,
injection of anti-CD25 Ab did not increase the number of
CD4+CD25+Foxp3+ Treg cells, although EA was conducted.
These results suggest that EA treatment induced a signiﬁcant
increase of CD4+CD25+Foxp3+ Treg cells.
3.3. The Eﬀect of EA on IgE Production and Th2 Inﬂammatory
Cytokines Secretion. WealsoevaluatedserumIgEproductionEvidence-Based Complementary and Alternative Medicine 5
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Figure 4: Eﬀect of EA on CD4+CD25+Foxp3EGFP Treg cells and Treg cells depletion in OVA-induced asthmatic pneumonocytes. PBS
treatment alone (control); OVA induction only (OVA); EA treatment after OVA induction (OVA + EA); anti-CD25 Ab injection after
OVA induction (OVA T); EA stimulation after OVA induction and anti-CD25 Ab injection (OVA T + EA). Isolated pneumonocytes were
stained with anti-CD4 allophycocyanin and anti-CD25 PE and submitted to ﬂow cytometry analysis. CD4+ cells were gated on and then
CD25+ Foxp3EGFP−positive cells were examined. The average ﬂow cytometry analysis data of all groups were depicted. There was an increase
of CD4+CD25+Foxp3+ Treg cells in OVA+EA group, but negligible data were shown in anti-CD25 Ab injected groups when compared with
OVA group. Data are shown as mean ±S.E.M. (∗∗∗P<0.001 versus control; ∗∗P<0.01 versus OVA; n = 6).
andTh2inﬂammatorymoleculesgeneratedbyOVA-induced
allergic asthma to ensure that EA decreased the levels of IgE
and BAL ﬂuid inﬂammatory cytokines, IL-4, IL-5, and IL-
13 (Figure 5). Serum IgE and Th2 cytokines in BAL ﬂuid
were measured 48h after the last EA treatment. Total IgE
titers and secretion of cytokines, IL-4, IL-5, and IL-13 were
signiﬁcantly elevated in all OVA-sensitized and challenged
mice when compared with the control mice. As expected,
EA-treated mice had decreased levels of IgE (OVA 17350 ±
1775ng/mL; OVA + EA 5795 ± 403.0ng/mL), IL-4 (OVA
149.3 ± 11.5 7p g / m g ;O V A+E A6 2 .67 ± 4.092pg/mg), IL-5
(OVA 176.9±14.81pg/mg; OVA + EA 53.81±5.487pg/mg),
and IL-13 (OVA 1943 ± 86.81pg/mg; OVA+EA 680.8 ±
91.12pg/mg). However, Treg-depleted mice (OVA Ta n d
OVA T + EA) that received 0.25mg of anti-CD25 Ab
after OVA induction showed no signiﬁcant diﬀerences in
comparison to the OVA group, even though EA treatments
were used.
3.4. The Eﬀect of EA on Eosinophil Inﬁltration. In the
OVA-immunized animals, the total number of inﬁltrating
cells was approximately 8 fold higher in the BAL ﬂuid.
However, EA treatment led to a 70% decrease in the total
number of inﬁltrating cells when compared with the OVA
group (Figure 6(a)). Eosinophils were counted based on
their morphological characteristics and were visualized by
Diﬀ-Quick staining. The number of eosinophils in EA-
treated animals was found to be a half of that in the
OVA group (Figure 6(a)). Histological analysis of lung tissue
sections revealed that the number of inﬂammatory cells,
especially eosinophils, was signiﬁcantly increased around the
perivascular and peribronchiolar regions in the OVA group,
the Treg depletion group and EA-treated Treg depletion
group, but was decreased in the EA-treated OVA-immunized
group (Figure 6(b)). The inﬁltration of inﬂammatory cells
was virtually absent in the control group. And by extension,
goblet cell hyperplasia and alteration in smooth muscle
thickness was present in the OVA group and no signiﬁcant
diﬀerence was observed between the Treg depletion mice
and EA-treated Treg depletion mice. In contrast, in the
EA-treated OVA group, a prominent decrease in goblet
cell hyperplasia and smooth muscle thickness was evident6 Evidence-Based Complementary and Alternative Medicine
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Figure 5: Total IgE production from serum and Th2 cytokines secretion from BAL ﬂuid in OVA-induced asthmatic mice. Total IgE and Th2
cytokines (IL-4, IL-5, and IL-13) levels were measured by ELISA. The data shown represent the means ± S.E.M. Statistics were conducted
using a Newman-Keuls multiple comparison test after one-way ANOVA. ∗∗∗P<0.001.
(Figures 6(c) and 6(d)). These data suggest that EA attenu-
ated eosinophils and inﬂammatory cells in OVA-immunized
mice through the modulation of CD4+CD25+Foxp3+ Treg
cells.
4. Discussion
Asthma is one of the most common chronic disorders of
the airways and aﬀects adults and children of all age [23–
25]. It has been estimated that worldwide, approximately
300 million people currently suﬀer from asthma, and about
180,000 deaths are associated with asthma each year [23, 26].
Allergic asthma is a complex disease that is characterized by
reversible airway obstruction, elevated serum levels of IgE,
chronic eosinophilic airway inﬂammation, airway remod-
elling, mucus hypersecretion, and AHR to bronchospasmo-
genic stimuli. Many asthma deaths are preventable, if treated
with the appropriate medical care. Current standard medica-
tions involve combination therapies, including inhaled corti-
costeroids,β2-agonists,leukotrienereceptorantagonists,and
others [26, 27]. However, these therapies produce potential
side eﬀects, such as retardation of growth, loss of bone
mass, induction of insulin resistance, and suppression of the
immune system, and do not consistently ameliorate airway
inﬂammation in many asthmatic individuals [24, 28, 29].
Therefore, there is a need for the development of safe and
eﬃcacious treatments [30, 31].
Clinical and experimental studies have shown that
sequential EA stimulation was eﬀective in the treatment
of stress-induced immunodeﬁciency and physical disorders
[32]. In recent meta-analysis study demonstrated that phar-
macoacupuncture, a combined therapy with acupuncture
and herbal medicine, possessed potential beneﬁcial eﬀects
on asthma [33]. Even though there were some debates about
placebo eﬀects of EA, recent systemic review suggested that
the acupoint stimulation elicited more speciﬁc responses
than sham acupuncture [34], in which similar eﬀects were
also shown in the present study.
Electrical stimulation can eﬀect physiological systems,
which include induction of the secretion of cytokines, acti-
vation of NK cell activity, and the release of opioid peptides
both in the periphery and the central nervous system [35–
37]. This investigation was based on our previous work,
where we found that EA regulates the expression of IgE and
Th1/Th2 cytokines involved in DNP-KLH immunized mice
[11, 12], and some of the studies and clinical experiences
have shown that EA reduces the inﬂammatory response
during allergy pathogenesis in an OVA-sensitized model and
rheumatoid arthritis [2, 3, 38]. Therefore, we investigated
the eﬀects of EA on CD4+CD25+Foxp3+ Treg cells and
the relationship between acupuncture mediated antiallergic
eﬀects and Treg-cell responses in a murine model of asthma.
To the best of our knowledge, this is the ﬁrst study whereEvidence-Based Complementary and Alternative Medicine 7
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Figure 6: Eﬀect of EA on various cell types in BAL ﬂuid and lung tissue. (a) Total number of inﬁltrating cell and eosinophils in BAL ﬂuid.
(b) Inﬂammatory cell inﬁltrates in experimental group. (c) Goblet hyperplasia in experimental group. (d) Comparison of the thickness of
thebronchiolar smooth muscle layer of experimental group. The data shown represent the means ±S.E.M. Statistics were conducted using a
Newman-Keuls multiple comparison test after one-way ANOVA. ∗∗∗P<0.001.
acupuncture-mediated anti-allergic asthma was evaluated in
regards to the modulation of CD4+CD25+Foxp3+ Treg cells.
Th1 cells are involved in delayed-type hypersensitivity
and cytotoxic response, while Th2 cells regulate allergic
diseases by activating B cells and regulating IgG and IgE
secretion [39]. Speciﬁc IgE production is a hallmark of aller-
gic diseases [40, 41]. In particular, IL-4 or IL-13 is essential
for the ﬁrst step in IgE production. In addition, IL-13 is both
necessary and suﬃcient to induce AHR. Other cytokines
including IL-5 and IL-6 can enhance IgE production [42–
46].Inthepresentstudy,ST36EAstimulationsuppressedthe
increased antigen-speciﬁc IgE production and Th2 cytokines
such as IL-4, IL-5, and IL-13 in OVA-induced allergic
asthmamice.IL-5isspeciﬁcallyinvolvedinthedevelopment,
priming, and survival of eosinophils [47]. Furthermore,
eosinophils, basophils, and some structural cells such as
epithelial and endothelial cells may also produce cytokines
and chemokines that amplify the inﬂammatory cascade [48,
49]. In addition, inﬁltration of eosinophils in the airway
results in the abnormal production of inﬂammatory proteins
and cytokines, such as eosinophil cationic protein, major
basicproteins,leukotrienes,IL-4,IL-5,IL-6,IL-13,andTGF-
β [24, 25, 50]. It has previously been shown that in the
OVA-immunized asthma model, AHR is closely associated
with eosinophilia, as evidenced by an increase in the number
of eosinophils in BAL ﬂuid [13, 18]. The results of the
present study indicated that EA stimulation led to increased
CD4+CD25+Foxp3+ Treg cells, whereas peribronchial and
perivascular inﬂammatory cell inﬁltrates were signiﬁcantly
suppressed.
In summary, we investigated the eﬀects of elec-
troacupuncture on CD4+CD25+Foxp3+ Treg cells and
the relationship between acupuncture mediated anti-allergic
eﬀects and regulatory T-cell responses in OVA-induced asth-
matic mice. EA stimulation attenuated the pathogenesis of
allergic asthma in an experimental mice model. The produc-
tion of serum IgE and Th2 cytokines in OVA- induced EA-
treated group were less than those in the OVA group. Also,
the total number of inﬂammatory cells and the inﬁltration
of eosinophils was reduced in EA-treated mice. The result
presented here indicate that sequential ST36 EA stimulation
promotes CD4+CD25+Foxp3+ Treg cells and suppresses the
increase in IgE production and Th2 cytokine secretion
in OVA-induced asthmatic mice presumably through the
modulation of Th1/Th2/Treg cell balance. Our results also
imply that EA can modulate Treg cells to downregulate
Th2 cytokines and inﬁltration of inﬂammatory cells, and
EA stimulation has strong immunomodulatory eﬀects on
CD4+CD25+Foxp3+ Treg cells, moving toward an immuno-
logically balanced state to maintain homeostasis.
5. Conclusions
Taken together, the identiﬁcation of EA stimulation-induced
CD4+CD25+Foxp3+ Treg cells will help elucidate the
mechanism of acupuncture-mediated anti-allergic eﬀects,
which will open a new route for therapy and may provide
new methods of treating allergic disorders.
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